Literature DB >> 2424401

Characteristics of verbal impairment in closed head injured patients.

M T Sarno, A Buonaguro, E Levita.   

Abstract

One hundred twenty-five closed head injured postcoma patients in a rehabilitation medicine center underwent standardized aphasia tests to determine the presence and nature of verbal deficits. Mean time since injury for the group was 45 weeks. All patients evidenced linguistic impairment which was only apparent on testing, not in conversation. The population fell into three relatively equally sized groups: classic aphasia, dysarthria accompanied by linguistic deficits, and "subclinical" aphasic deficits. No patient with a history of coma after closed head injury was spared defective performance on selected language tasks. The patient groups reflected a severity continuum ranging from aphasia, the most severely impaired group, to the least impaired, the subclinical aphasia group. Further, closed head injured patients with a history of coma who manifest motor speech impairment (dysarthria) also manifest linguistic processing deficits. The study results suggest that linguistic functions are particularly vulnerable in severe head injury.

Entities:  

Mesh:

Year:  1986        PMID: 2424401

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  3 in total

1.  Conversational synchrony in the communicative interactions of individuals with traumatic brain injury.

Authors:  Rupa Gupta Gordon; Arianna Rigon; Melissa C Duff
Journal:  Brain Inj       Date:  2015-06-17       Impact factor: 2.311

Review 2.  Prosodic processing post traumatic brain injury - a systematic review.

Authors:  Gabriela Ilie; Michael D Cusimano; Wenshan Li
Journal:  Syst Rev       Date:  2017-01-04

3.  Recovery of injured Broca's portion of arcuate fasciculus in the dominant hemisphere in a patient with traumatic brain injury.

Authors:  Sung Ho Jang; Ji Wan Ha; Hyun Young Kim; You Sung Seo
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.